Secondary Hypogonadism Diagnosis
Diagnose secondary hypogonadism by confirming low morning testosterone (<10.5 nmol/L or ~300 ng/dL) on at least two separate occasions combined with low or inappropriately normal LH/FSH levels, along with specific symptoms of testosterone deficiency. 1
Diagnostic Algorithm
Step 1: Clinical Assessment
Symptom Evaluation - Look for these specific manifestations:
- Sexual symptoms: Reduced frequency of sexual intercourse, decreased masturbation, delayed ejaculation 1
- Physical symptoms: Hot flushes, decreased energy, reduced physical strength/function/activity 1
- Cognitive symptoms: Concentration difficulties, memory problems, sleep disturbances 1
Critical History Elements:
- Evaluate for pituitary disorders (tumors, hemochromatosis) 2
- Document surgical history affecting the hypothalamic-pituitary axis 1
- Identify medications that suppress gonadotropins: opiates, GnRH agonists/antagonists, glucocorticoids, estrogens, progestogens 3
- Assess for obesity and metabolic syndrome (major causes of functional secondary hypogonadism) 3
- Determine fertility desires immediately - this fundamentally changes treatment approach 1, 3
Step 2: Physical Examination
Measure and document:
- Body mass index (BMI) and waist circumference (obesity causes secondary hypogonadism via increased aromatization of testosterone to estradiol, suppressing LH) 3, 2
Step 3: Laboratory Confirmation
Initial Testing:
- Morning total testosterone (8-10 AM) on at least two separate days - this is mandatory 1, 2, 4
- Avoid testing during acute illness (results transiently suppressed) 1, 2
Confirmatory Testing (if initial testosterone is low):
- LH and FSH levels - the defining test for secondary hypogonadism 3, 2
- Free testosterone by equilibrium dialysis - especially critical in obese patients where SHBG is altered 3, 2
- Sex hormone-binding globulin (SHBG) - low levels in obesity affect total testosterone interpretation 3
- Prolactin - measure when testosterone is low with low/normal LH to exclude prolactinoma 2
Step 4: Imaging for Structural Lesions
MRI of hypothalamic-pituitary region is indicated when:
These thresholds are more sensitive than the older Endocrine Society recommendation of testosterone <5.2 nmol/L and better predict structural abnormalities like pituitary tumors or hypothalamic lesions. 5
Treatment Options
For Men NOT Seeking Fertility
Testosterone Therapy (TTh) is first-line:
- Starting dose: 50 mg testosterone gel applied topically once daily to shoulders/upper arms 4
- Check morning pre-dose testosterone at 14 days 4
- Target range: 300-1,000 ng/dL 4
- Increase to 100 mg daily if levels remain <300 ng/dL (maximum dose) 4
Lifestyle modifications should be combined with TTh:
- Weight loss through low-calorie diets can reverse obesity-associated secondary hypogonadism 1
- Physical activity provides benefits correlating with exercise duration 1
- However, testosterone increases from lifestyle alone are modest (1-2 nmol/L), so combining with TTh yields better outcomes 1
For Men Seeking Fertility
Gonadotropin therapy is mandatory - testosterone therapy is absolutely contraindicated as it suppresses spermatogenesis:
- Combined hCG and FSH therapy provides optimal outcomes 1
- This maintains testosterone levels while preserving fertility 1, 3
- Recombinant formulations are comparable to urinary-derived preparations 1
Absolute Contraindications to Testosterone Therapy
Specific Treatment Recommendations by Indication
Use TTh as first-line for:
- Mild erectile dysfunction (strong recommendation) 1
Combine PDE5 inhibitors with TTh for:
- Severe erectile dysfunction (weak recommendation) 1
Do NOT use TTh for:
- Eugonadal men (strong recommendation) 1
- Weight reduction or cardiometabolic improvement as primary goal (weak recommendation) 1
- Improving cognition, vitality, or physical strength in aging men (strong recommendation) 1
Critical Pitfalls to Avoid
- Never prescribe testosterone to men wanting fertility - it will suppress spermatogenesis and worsen their condition 3
- Do not test testosterone during acute illness - results are unreliable 1, 2
- Do not rely on single testosterone measurement - at least two morning samples required 1, 2
- Do not skip LH/FSH testing - this distinguishes primary from secondary hypogonadism and fundamentally changes management 3, 2
- In obese patients, measure free testosterone - total testosterone is less reliable due to altered SHBG 3, 2
- Consider MRI with very low testosterone (≤6.1 nmol/L) or LH (≤1.9 U/L) - may indicate pituitary tumor requiring different management 5